TRANSGLUTAMINASE FACILITATES THE FORMATION OF POLYMERS OF THE BETA-AMYLOID PEPTIDE

被引:96
作者
DUDEK, SM [1 ]
JOHNSON, GVW [1 ]
机构
[1] UNIV ALABAMA,DEPT PSYCHIAT & BEHAV NEUROBIOL,BIRMINGHAM,AL 35294
关键词
ALZHEIMERS DISEASE; AMYLOID BETA-PROTEIN; DUTCH-TYPE AMYLOIDOSIS;
D O I
10.1016/0006-8993(94)90688-2
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
One of the major pathological characteristics of Alzheimer's disease is the increased number of amyloid-containing senile plaques within the brain. The dense cores of these plaques are composed primarily of highly insoluble aggregates of a 39-43-residue peptide referred to as the beta-amyloid peptide (beta A). The mechanisms by which these insoluble extracellular deposits of beta A are formed remain unknown. In this study, the cross-linking of beta A by the calcium-dependent enzyme, transglutaminase was examined. Transglutaminases are a family of enzymes which are found in brain, and catalyse the cross-linking of specific proteins into insoluble polymers. Synthetic beta A (1-40) was readily cross-linked by transglutaminase, forming multimers in a time-dependent fashion. Furthermore, a second peptide with a substitution similar to that in the Dutch-type hereditary amyloidosis mutation (Glu(22) to Gln) was also found to be a substrate for transglutaminase. Since transglutaminase covalently cross-links proteins through glutamine residues, it is suggested that transglutaminase contributes to amyloid deposition in Dutch-type hereditary amyloidosis, and possibly Alzheimer's disease.
引用
收藏
页码:129 / 133
页数:5
相关论文
共 33 条
[11]   ALZHEIMERS-DISEASE - INITIAL REPORT OF THE PURIFICATION AND CHARACTERIZATION OF A NOVEL CEREBROVASCULAR AMYLOID PROTEIN [J].
GLENNER, GG ;
WONG, CW .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1984, 120 (03) :885-890
[12]   TRANSGLUTAMINASES - MULTIFUNCTIONAL CROSS-LINKING ENZYMES THAT STABILIZE TISSUES [J].
GREENBERG, CS ;
BIRCKBICHLER, PJ ;
RICE, RH .
FASEB JOURNAL, 1991, 5 (15) :3071-3077
[13]   AMYLOID DEPOSITION AS THE CENTRAL EVENT IN THE ETIOLOGY OF ALZHEIMERS-DISEASE [J].
HARDY, J ;
ALLSOP, D .
TRENDS IN PHARMACOLOGICAL SCIENCES, 1991, 12 (10) :383-388
[14]   CELL-DEATH AND THE CELL-CYCLE - A RELATIONSHIP BETWEEN TRANSFORMATION AND NEURODEGENERATION [J].
HEINTZ, N .
TRENDS IN BIOCHEMICAL SCIENCES, 1993, 18 (05) :157-159
[15]   KUNITZ PROTEASE INHIBITOR-CONTAINING AMYLOID-BETA PROTEIN-PRECURSOR IMMUNOREACTIVITY IN ALZHEIMERS-DISEASE [J].
HYMAN, BT ;
TANZI, RE ;
MARZLOFF, K ;
BARBOUR, R ;
SCHENK, D .
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 1992, 51 (01) :76-83
[16]   CROSS-LINKING OF A SYNTHETIC PARTIAL-LENGTH (1-28) PEPTIDE OF THE ALZHEIMER BETA/A4 AMYLOID PROTEIN BY TRANSGLUTAMINASE [J].
IKURA, K ;
TAKAHATA, K ;
SASAKI, R .
FEBS LETTERS, 1993, 326 (1-3) :109-111
[17]   SEEDING ONE-DIMENSIONAL CRYSTALLIZATION OF AMYLOID - A PATHOGENIC MECHANISM IN ALZHEIMERS-DISEASE AND SCRAPIE [J].
JARRETT, JT ;
LANSBURY, PT .
CELL, 1993, 73 (06) :1055-1058
[18]  
Johnson G. V. W., 1993, Society for Neuroscience Abstracts, V19, P1639
[19]   PROTEOLYSIS OF MICROTUBULE-ASSOCIATED PROTEIN-2 AND TUBULIN BY CATHEPSIN-D [J].
JOHNSON, GVW ;
LITERSKY, JM ;
WHITAKER, JN .
JOURNAL OF NEUROCHEMISTRY, 1991, 57 (05) :1577-1583
[20]   ADVANCES IN ALZHEIMERS-DISEASE [J].
KATZMAN, R ;
SAITOH, T .
FASEB JOURNAL, 1991, 5 (03) :278-286